ALEXANDRIA, Va., April 21 -- United States Patent no. 12,606,544, issued on April 21, was assigned to DIZAL (JIANGSU) PHARMACEUTICAL Co. LTD. (Shanghai).
"JAK1 selective kinase inhibitor" was invented by Changhe Qi (Shanghai), Honchung Tsui (Shanghai), Qingbei Zeng (Shanghai), Zhenfan Yang (Shanghai) and Xiaolin Zhang (Shanghai).
According to the abstract* released by the U.S. Patent & Trademark Office: "Disclosed herein are compounds of Formula (I), and pharmaceutically acceptable salts thereof, that are useful as JAK kinase inhibitors. Also disclosed are pharmaceutical compositions comprising one or more compounds of Formula (I), and methods of using such compounds or compositions to treat respiratory conditions (e.g., asthma or COPD)."...